N. F. de Moraes

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

R. Lopes, J. Fareed, E. Ramacciotti, 2021, The Lancet.

Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial

Chang Chiann, R. Lopes, E. Ramacciotti, 2021, American Heart Journal.

Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial

P. Pelosi, R. E. Marques, R. Luiz, 2020, European Respiratory Journal.